Your browser doesn't support javascript.
loading
A STING Agonist Given with OX40 Receptor and PD-L1 Modulators Primes Immunity and Reduces Tumor Growth in Tolerized Mice.
Foote, Jeremy B; Kok, Marleen; Leatherman, James M; Armstrong, Todd D; Marcinkowski, Bridget C; Ojalvo, Laureen S; Kanne, David B; Jaffee, Elizabeth M; Dubensky, Thomas W; Emens, Leisha A.
Afiliación
  • Foote JB; Department of Oncology, Kimmel Cancer Center, Johns Hopkins School of Medicine, Baltimore, Maryland.
  • Kok M; Department of Molecular and Comparative Pathobiology, Johns Hopkins School of Medicine, Baltimore, Maryland.
  • Leatherman JM; Department of Oncology, Kimmel Cancer Center, Johns Hopkins School of Medicine, Baltimore, Maryland.
  • Armstrong TD; Department of Oncology, Kimmel Cancer Center, Johns Hopkins School of Medicine, Baltimore, Maryland.
  • Marcinkowski BC; Department of Oncology, Sidney Kimmel Comprehensive Cancer Center, Johns Hopkins University, Baltimore, Maryland.
  • Ojalvo LS; Skip Viragh Center for Pancreatic Cancer Clinical Research, Johns Hopkins University, Baltimore, Maryland.
  • Kanne DB; Sol Goldman Pancreatic Cancer Research Center, Johns Hopkins University, Baltimore, Maryland.
  • Jaffee EM; Department of Oncology, Kimmel Cancer Center, Johns Hopkins School of Medicine, Baltimore, Maryland.
  • Dubensky TW; Department of Oncology, Sidney Kimmel Comprehensive Cancer Center, Johns Hopkins School of Medicine, Baltimore, Maryland.
  • Emens LA; Kelly Gynecologic Oncology Service, Johns Hopkins School of Medicine, Baltimore, Maryland.
Cancer Immunol Res ; 5(6): 468-479, 2017 06.
Article en En | MEDLINE | ID: mdl-28483787

Texto completo: 1 Colección: 01-internacional Asunto principal: Receptores OX40 / Antígeno B7-H1 / Proteínas de la Membrana / Neoplasias Límite: Animals Idioma: En Revista: Cancer Immunol Res Año: 2017 Tipo del documento: Article

Texto completo: 1 Colección: 01-internacional Asunto principal: Receptores OX40 / Antígeno B7-H1 / Proteínas de la Membrana / Neoplasias Límite: Animals Idioma: En Revista: Cancer Immunol Res Año: 2017 Tipo del documento: Article